Sol-gel technologies reports second quarter 2022 financial results and provides corporate update

Ness ziona, israel, aug. 04, 2022 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced today financial results for the second quarter ended june 30, 2022 and provided a corporate update.
SLGL Ratings Summary
SLGL Quant Ranking